HES
66
3
MA
67
-5
DE
36
-2
AA
38
-2
NOC
40
-10
FRT
48
2
MMM
42
5
CHD
48
-3
CMG
69
-3
T
48
3
QCOM
55
-2
CF
53
2
LOW
58
2
DRI
56
2
TRV
56
-2
IFF
53
2
CVX
38
6
EMC
53
-3
ROK
67
5
AON
60
2
HES
66
3
MA
67
-5
DE
36
-2
AA
38
-2
NOC
40
-10
FRT
48
2
MMM
42
5
CHD
48
-3
CMG
69
-3
T
48
3
QCOM
55
-2
CF
53
2
LOW
58
2
DRI
56
2
TRV
56
-2
IFF
53
2
CVX
38
6
EMC
53
-3
ROK
67
5
AON
60
2
Financhill
Back

Ovid Therapeutics Vs. Aritzia Industry Stock Comparison

Buy
63

OVID
Ovid Therapeutics

Last Price:
1.17
Seasonality Move:
-0.69%
Sell
40

ATZAF
Aritzia

Last Price:
32.69
Seasonality Move:
14.48%
Buy
63
Ovid Therapeutics (OVID) is a Buy

Is Ovid Therapeutics a Buy, Sell or Hold?

  • The current Ovid Therapeutics [OVID] share price is $1.23. The Score for OVID is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
  • OVID is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
40
Aritzia (ATZAF) is a Sell

Is Aritzia a Buy, Sell or Hold?

  • The current Aritzia [ATZAF] share price is $33.13. The Score for ATZAF is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • ATZAF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

OVID Stock Price Chart

What is Ovid Therapeutics's stock price today?

  • The Ovid Therapeutics share price today is $1.23
    The current trend is moderately bearish and OVID is experiencing slight buying pressure.

ATZAF Stock Price Chart

What is Aritzia's stock price today?

  • The Aritzia share price today is $33.13
    The current trend is relatively stagnant and ATZAF is experiencing slight buying pressure.

OVID Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.03 Buy
Relative Strength Index (14 RSI): 52 Buy
Chaikin Money Flow: 168484 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.14 - 1.26) Buy
Bollinger Bands (100): (0.92 - 1.22) Buy

ATZAF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.72 Sell
Relative Strength Index (14 RSI): 51.58 Buy
Chaikin Money Flow: 485 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (30.46 - 34.6) Buy
Bollinger Bands (100): (30.22 - 35.52) Buy

OVID Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.27 Sell
20-day SMA: 1.22 Buy
50-day SMA: 1.16 Buy
200-day SMA: 2.11 Sell
8-day EMA: 1.26 Sell
20-day EMA: 1.22 Buy
50-day EMA: 1.2 Buy
200-day EMA: 1.85 Sell

ATZAF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 31.85 Buy
20-day SMA: 31.82 Buy
50-day SMA: 34.06 Sell
200-day SMA: 29.54 Buy
8-day EMA: 31.74 Buy
20-day EMA: 32.3 Buy
50-day EMA: 33.02 Buy
200-day EMA: 30 Buy

Ovid Therapeutics Earnings Growth & OVID Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.20 per share, and a decrease next year of $0.24 per share.

Aritzia Earnings Growth & ATZAF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.68 per share, and an increase next year of $0.57 per share.

Ovid Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Aritzia Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):